Target intelligence / Profile preview

T cell receptor alpha variable 8-1 (TRAV8-1)

Target
TRAV8-1
Molecular classification
Variable region of immunoreceptor, Part of T cell receptor (Receptor), Immunoglobulin superfamily
01

Overview

T cell receptor alpha variable 8-1 (TRAV8-1) is a gene segment encoding a variable region of the alpha chain of the T cell receptor (TCR), which is essential for the recognition of foreign antigens presented by major histocompatibility complex (MHC) molecules on the surface of antigen-presenting cells. The TCR is a heterodimer, typically consisting of alpha and beta chains, each with variable (V), joining (J), and constant (C) regions. The TRAV8-1 segment provides diversity to the antigen-recognition site of the TCR through somatic recombination events that generate a wide range of antigen specificities. This diversity underlies the adaptive immune response, enabling T cells to recognize and respond to numerous pathogens. The alpha variable region (including TRAV8-1) participates in the first step of immune recognition, ultimately leading to intracellular signaling cascades that activate T lymphocytes for immune responses[1][2][3]. Essentially, TRAV8-1 is a gene segment used in the generation of T cell receptors but is not itself a drug target, an enzyme, or a receptor protein product; rather, it is a component that contributes to the diversity of antigen recognition in the immune system.

Other names
TRAV8-1TCRAV1S1TCRAV8S1TRAV81
02

Biological functions

Antigen recognitionAdaptive immune responseSignal transduction (as part of the TCR complex)
03

Disease associations

Other (contributes to immune system function, but no direct disease association in isolation)

Beyond the preview

Go deeper on T cell receptor alpha variable 8-1 (TRAV8-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor alpha variable 8-1 (TRAV8-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call